OptiNose UK Ltd Company Profile
OptiNose is a drug delivery company with breakthrough technology set to transform the static nasal drug delivery market. The Company was founded in 2000 to commercialize a novel nasal drug delivery system that achieves targeted delivery to sites that are poorly accessed by existing nasal sprays. The technology is unparalleled in its ability to effectively deliver drugs to specific sites within the nose, while uniquely preventing drug distribution to the lungs. This provides significant advantages as rival companies focus principally on formulation-based approaches to nasal delivery; these competing technologies cannot compensate for the poor drug deposition patterns of existing devices.
Location
Berkeley HouseHunts Rise
South Marston Park
Wiltshire
SN3 4TG
United Kingdom
Contact
Phone: 44 (0)179 383 4928
Fax: 44 (0)179 382 5986
Email: info@optinose.co.uk
News Articles
YARDLEY, Pa., Nov. 14, 2012 /PRNewswire/ -- OptiNose US Inc. today announced that the phase III TARGET study successfully met its primary endpoint, finding the new 16 mg OptiNose sumatriptan product p...
First patient enrolled in head-to-head efficacy trial comparing OptiNose sumatriptan drug delivery to sumatriptan tablets YARDLEY, Pa., Oct. 2, 2012 /PRNewswire/ -- OptiNose US Inc. today announced re...
YARDLEY, Pa., Oct. 18, 2012 /PRNewswire/ -- OptiNose US Inc., today announced the publication of results from a study which showed that the proportion of the dose delivered to the blood vessel-ri...
YARDLEY, Pa., Oct. 2, 2012 /PRNewswire/ -- OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered B...
YARDLEY, Pa., Oct. 2, 2012 /PRNewswire/ -- OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered B...
Pharma Tech Industries Selected to Manufacture Innovative Nasal Delivery System for NDA Submission
Pharma Tech Industries (PTI), the largest pharmaceutical contract manufacturer and packager of powder products in the world, has been selected to handle filling, assembly and pack...
OptiNose Receives Grant to Fund Nose-to-Brain Research in Autism Spectrum Disorders
YARDLEY, Pa., Nov. 8, 2012 /PRNewswire/ -- OptiNose US Inc., today announced that its Norwegian affiliate was awarded NOK 12.3 million (USD $2.1 million) by the Research Council of Norway to stu...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
OptiNose is a drug delivery company with breakthrough bi-directional nasal technology set to transform the static nasal drug delivery market. Founded in 2000, OptiNoseâs devi...
OptiNose is a drug delivery company with breakthrough technology set to transform the static nasal drug delivery market. The Company was founded in 2000 to commercialize a novel nasal drug delivery sy...
More Information about "OptiNose UK Ltd" on BioPortfolio
We have published hundreds of OptiNose UK Ltd news stories on BioPortfolio along with dozens of OptiNose UK Ltd Clinical Trials and PubMed Articles about OptiNose UK Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OptiNose UK Ltd Companies in our database. You can also find out about relevant OptiNose UK Ltd Drugs and Medications on this site too.
